Rice Hall James & Associates LLC Sells 1,479 Shares of Teleflex Incorporated (NYSE:TFX)

Rice Hall James & Associates LLC trimmed its stake in Teleflex Incorporated (NYSE:TFX) by 15.6% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,026 shares of the medical technology company’s stock after selling 1,479 shares during the period. Rice Hall James & Associates LLC’s holdings in Teleflex were worth $1,985,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of TFX. Cromwell Holdings LLC raised its holdings in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after buying an additional 49 shares during the period. Canada Pension Plan Investment Board purchased a new stake in shares of Teleflex in the second quarter worth approximately $42,000. GAMMA Investing LLC raised its holdings in shares of Teleflex by 131.1% in the third quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after buying an additional 97 shares during the period. Versant Capital Management Inc raised its holdings in shares of Teleflex by 20,700.0% in the second quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock worth $44,000 after buying an additional 207 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Teleflex by 78.2% in the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock worth $48,000 after buying an additional 93 shares during the period. 95.62% of the stock is owned by institutional investors.

Teleflex Stock Performance

NYSE:TFX opened at $211.21 on Friday. The firm has a market capitalization of $9.95 billion, a PE ratio of 41.99, a price-to-earnings-growth ratio of 1.82 and a beta of 1.18. The business’s fifty day moving average price is $239.55 and its 200 day moving average price is $223.93. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.44. Teleflex Incorporated has a 12 month low of $190.49 and a 12 month high of $257.85.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the prior year, the firm posted $3.64 earnings per share. Teleflex’s revenue for the quarter was up 2.4% on a year-over-year basis. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.97 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.64%. Teleflex’s dividend payout ratio is presently 27.04%.

Analyst Ratings Changes

Several brokerages have recently weighed in on TFX. Mizuho reduced their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday. Stephens raised their price objective on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Truist Financial raised their price objective on Teleflex from $247.00 to $255.00 and gave the stock a “hold” rating in a report on Monday, October 14th. Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday. Four equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Teleflex currently has an average rating of “Moderate Buy” and a consensus price target of $262.75.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Stuart A. Randle sold 2,674 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares in the company, valued at $1,313,159.28. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.43% of the stock is currently owned by insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.